Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications.

ABSTRACT: Cancer has become an increasingly important public health issue owing to its high morbidity and mortality rates. Although traditional treatment methods are relatively effective, they have limitations such as highly toxic side effects, easy drug resistance, and high individual variability. Meanwhile, emerging therapies remain limited, and their actual anti-tumor effects need to be improved. Nanotechnology has received considerable attention for its development and application. In particular, artificial nanocarriers have emerged as a crucial approach for tumor therapy. However, certain deficiencies persist, including immunogenicity, permeability, targeting, and biocompatibility. The application of erythrocyte-derived materials will help overcome the above problems and enhance therapeutic eff

SUBMITTER: Ding J 

PROVIDER: S-EPMC10767221 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature